Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04664309 · ClinicalTrials.gov registry record
Understanding Immunity to the COVID-19 Vaccines
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 43
- Enrollment target
NCT04664309: Completed study, sponsored by Stanford University.
NCT04664309 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04664309 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
The purpose of this study is to test over time immunity to the COVID-19 vaccines. Adults who are receiving COVID-19 vaccines will be invited to participate.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2021-03-26 |
| Est. Completion | 2022-01-06 |
What the finished NCT04664309 record still lists
NCT04664309 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT04664309 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04664309 about?
NCT04664309 is a clinical study titled "Understanding Immunity to the COVID-19 Vaccines". The purpose of this study is to test over time immunity to the COVID-19 vaccines. Adults who are receiving COVID-19 vaccines will be invited to participate.
What is the current status of trial NCT04664309?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2021-03-26. Estimated completion is 2022-01-06.
What interventions are being tested in trial NCT04664309?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04664309?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI